Belite Bio, Inc (BLTE) Operating cash flow 2020–2025
Belite Bio, Inc (BLTE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$37.0MFY2025 · since FY2020: -$4.4M → -$37.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$37.0M | -26.5% |
| FY2024 | -$29.2M | +2.0% |
| FY2023 | -$29.8M | -160.4% |
| FY2022 | -$11.5M | -53.3% |
| FY2021 | -$7.5M | -68.3% |
| FY2020 | -$4.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice